Platelet thromboxane inhibition by low‐dose aspirin in polycythemia vera: Ex vivo and in vivo measurements and in silico simulation

Low‐dose aspirin is currently recommended for patients with polycythemia vera (PV), a myeloproliferative neoplasm with increased risk of arterial and venous thromboses. Based on aspirin pharmacodynamics in essential thrombocythemia, a twice‐daily regimen is recommended for patients with PV deemed at...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrucci, Giovanna, Giaretta, Alberto, Ranalli, Paola, Cavalca, Viviana, Dragani, Alfredo, Porro, Benedetta, Hatem, Duaa, Habib, Aida, Tremoli, Elena, Patrono, Carlo, Rocca, Bianca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747129/
https://www.ncbi.nlm.nih.gov/pubmed/36200184
http://dx.doi.org/10.1111/cts.13415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9747129/
https://www.ncbi.nlm.nih.gov/pubmed/36200184
http://dx.doi.org/10.1111/cts.13415

Ejemplares similares